← Back to Search

Behavioral Intervention

Jaspr intervention with enhanced treatment as usual (ETAU) for Suicide Attempt (Jaspr-PartA Trial)

N/A
Recruiting
Led By Edwin D Boudreaux, PhD
Research Sponsored by University of Massachusetts, Worcester
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Cognitively and emotionally capable of consent and engaging in Jaspr app
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up duration of enrollment = 30 months
Awards & highlights

Jaspr-PartA Trial Summary

This trial aims to evaluate a suicide prevention technology called Jaspr Health. It helps deliver evidence-based practices for suicide prevention while making use of waiting time in emergency departments. The trial will assess the effectiveness and

Who is the study for?
This trial is for individuals in emergency departments who have attempted suicide, are having suicidal thoughts, or engaged in self-harm. Specific eligibility details aren't provided, but typically participants must meet certain health criteria to be included.Check my eligibility
What is being tested?
The study is testing the Jaspr Health app combined with Just-in-Time Adaptive Help (JAH) against usual treatment. It aims to use patients' waiting time effectively by providing evidence-based practices for suicide prevention.See study design
What are the potential side effects?
Since this trial involves a digital intervention rather than medication, traditional side effects are not applicable. However, there may be psychological impacts from engaging with the content that should be monitored.

Jaspr-PartA Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I can understand and agree to participate in the study using the Jaspr app.

Jaspr-PartA Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~duration of enrollment = 30 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and duration of enrollment = 30 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Suicide composite, binary
Secondary outcome measures
Suicidal attempt
Suicidal behavior
Suicidal ideation severity
Other outcome measures
Clinician acceptability
Costs
ED visit satisfaction
+22 more

Jaspr-PartA Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Jaspr intervention with enhanced treatment as usual (ETAU)Experimental Treatment2 Interventions
Subjects in this arm will receive ETAU in addition, they will complete a guided Suicide Status Interview (SSI), Safety Planning, and Lethal means counseling on the Jaspr tablet-based app before open access to the Jaspr resource library. Subjects can sign up to receive JAH mobile app.
Group II: Enhanced treatment as usual (ETAU) aloneActive Control1 Intervention
Subjects in this arm will receive the usual care for patients with suicidal risk at UMass Memorial ED that may include a behavioral health evaluation by a trained clinician, and environmental safety precautions dictated by risk level (Mild, Moderate, High). Individuals deemed appropriate for discharge undergo discharge planning and offered a personalized safety plan using the Stanley-Brown Safety Planning Intervention, including lethal means safety counseling.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
ETAU
2015
Completed Phase 3
~240

Find a Location

Who is running the clinical trial?

University of Massachusetts, WorcesterLead Sponsor
343 Previous Clinical Trials
985,940 Total Patients Enrolled
1 Trials studying Suicide Attempt
27,908 Patients Enrolled for Suicide Attempt
National Institute of Mental Health (NIMH)NIH
2,786 Previous Clinical Trials
2,689,029 Total Patients Enrolled
4 Trials studying Suicide Attempt
28,251 Patients Enrolled for Suicide Attempt
Evidence-Based Practice Institute, Seattle, WAIndustry Sponsor
8 Previous Clinical Trials
29,107 Total Patients Enrolled
1 Trials studying Suicide Attempt
27,908 Patients Enrolled for Suicide Attempt

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are patients currently able to participate in this ongoing trial?

"According to the information provided on clinicaltrials.gov, this particular trial is currently not seeking participants. The initial posting of the study was made on January 16th, 2024, and it has been last edited on the same date. However, it's worth noting that there are presently 464 other ongoing clinical trials actively enrolling patients."

Answered by AI
~447 spots leftby Apr 2027